Home Tools
Log in
Cart

Relacatib

Catalog No. T40463   CAS 362505-84-8
Synonyms: SB-462795

Relacatib (SB-462795) is a novel, potent, and orally active inhibitor of human cathepsins K, L, and V. It exhibits high affinity for these enzymes, with Ki values of 41 pM, 68 pM, and 53 pM, respectively. Moreover, Relacatib effectively inhibits endogenous cathepsin K in situ in human osteoclasts, as well as human osteoclast-mediated bone resorption, with IC 50 values of 45 nM and 70 nM, respectively. Additionally, in vitro studies demonstrate Relacatib's inhibitory effect on bone resorption in human tissue, while in vivo studies on cynomolgus monkeys further validate its efficacy in reducing bone resorption.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
Relacatib Chemical Structure
Relacatib, CAS 362505-84-8
Pack Size Availability Price/USD Quantity
5 mg Inquiry $ 1,970.00
Bulk Inquiry
Get quote
Contact us for more batch information
Biological Description
Chemical Properties
Storage & Solubility Information
Description Relacatib (SB-462795) is a novel, potent, and orally active inhibitor of human cathepsins K, L, and V. It exhibits high affinity for these enzymes, with Ki values of 41 pM, 68 pM, and 53 pM, respectively. Moreover, Relacatib effectively inhibits endogenous cathepsin K in situ in human osteoclasts, as well as human osteoclast-mediated bone resorption, with IC 50 values of 45 nM and 70 nM, respectively. Additionally, in vitro studies demonstrate Relacatib's inhibitory effect on bone resorption in human tissue, while in vivo studies on cynomolgus monkeys further validate its efficacy in reducing bone resorption.
Targets&IC50 Cathepsin V:53 pM , Cathepsin L:68 pM , Cathepsin K:41 pM (Ki)
In vitro Relacatib, when tested in vitro using human osteoclastoma-derived osteoclasts on bovine cortical bone slices, exhibits significant inhibitory activity. The compound's potency is evidenced by its Ki values: 0.041 nM (human cathepsin K), 0.068 nM (human cathepsin L), 0.063 nM (human cathepsin V), 1.6 nM (human cathepsin S), and 13 nM (human cathepsin B)[1]. Moreover, Relacatib demonstrates specific inhibitory effects against various cathepsins in animal models: in monkeys, Ki values are 0.041 nM (cathepsin K), 0.28 nM (cathepsin L), 0.72 nM (cathepsin V), and 11 nM (cathepsin B); in mice, a Ki value of 0.20 nM (cathepsin L); and in rats, 0.17 nM (cathepsin L)[2], showcasing its broad-spectrum activity across different species.
In vivo Relacatib administered to male Sprague-Dawley rats (1-2 mg/kg via 0.5 h intravenous infusion; 2-4 mg/kg via oral bolus gavage) demonstrates pharmacokinetic parameters including a half-life (T 1/2) of 109 minutes, a clearance rate (CL) of 19.5 mL/min/kg, and a steady-state volume of distribution (Vdss) of 1.86 L/kg. In monkeys, these parameters were observed as 168 minutes, 11.7 mL/min/kg, and 1.79 L/kg, respectively, in pharmacokinetic iv/po crossover studies. The oral bioavailability of Relacatib was found to be 28% in monkeys and 89.4% in rats[1]. SB-462795, administered as a subcutaneous injection at 12 mg/kg with blood samples collected at 1.5, 4, 24, 48, and 72 hours post-administration, significantly inhibits bone resorption, evidenced by reduced serum levels of the N-telopeptides (NTx) and C-telopeptides (CTx) of type I collagen, markers of bone resorption. However, no significant differences in serum osteocalcin levels, a biomarker of osteoblast activity, were observed between SB-462795 and vehicle-treated animals, except for a noteworthy reduction at 48 hours (42% lower than baseline with SB-462795 vs. 18% lower with vehicle treatment)[2]. This study was conducted using a Cynomolgus monkey model at a dosage of 12 mg/kg for subcutaneous injection, indicating effective suppression of bone resorption from 1.5 to 72 hours post-dosing[2].
Synonyms SB-462795
Molecular Weight 540.64
Formula C27H32N4O6S
CAS No. 362505-84-8

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

TargetMolReferences and Literature

1. Dennis S Yamashita, et al. Structure Activity Relationships of 5-, 6-, and 7-methyl-substituted azepan-3-one Cathepsin K Inhibitors.J Med Chem 2. S Kumar, et al.A Highly Potent Inhibitor of Cathepsin K (Relacatib) Reduces Biomarkers of Bone Resorption Both in Vitro and in an Acute Model of Elevated Bone Turnover in Vivo in Monkeys.Bone. 2007 Jan;40(1):122-31.

TargetMolDose Conversion

You can also refer to dose conversion for different animals. More

TargetMol In vivo Formulation Calculator (Clear solution)

Step One: Enter information below
Dosage
mg/kg
Average weight of animals
g
Dosing volume per animal
ul
Number of animals
Step Two: Enter the in vivo formulation
% DMSO
%
% Tween 80
% ddH2O
Calculate Reset

TargetMolCalculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculation
Molecular Weight Calculator
=
X
X

Molarity Calculator allows you to calculate the

  • Mass of a compound required to prepare a solution of known volume and concentration
  • Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Concentration of a solution resulting from a known mass of compound in a specific volume
See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

X
=
X

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

=
/

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

Relacatib 362505-84-8 SB462795 SB 462795 SB-462795 inhibitor inhibit

 

TargetMol